Based on this, the HGF/c-MET pathway gains its significance in NAFLD treatment as it controls liver lipid metabolism on various fronts starting from fatty acid uptake to the resolution of excess fats by controlling β-oxidation and VLDL secretion. This evidence concerns the gene MET and metabolic dysfunction-associated steatotic liver disease.